News Thermo Fisher Scientific

Equities

TMO

US8835561023

Market Closed - Nyse Other stock markets 04:00:05 2024-04-23 pm EDT			5-day change	1st Jan Change
575.1 ^USD	+4.87%		+3.71%	+8.35%

01:29pm	Futures Mostly Rise in Premarket Ahead of More Corporate Earnings; Asia, Europe Up	MT
01:14pm	Tech Strength Lifts Wall Street Pre-Bell; Asia Rallies, Europe Up	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Futures Mostly Rise in Premarket Ahead of More Corporate Earnings; Asia, Europe Up	07:29am	MT
Tech Strength Lifts Wall Street Pre-Bell; Asia Rallies, Europe Up	07:14am	MT
Thermo Fisher lifts profit forecast as medical equipment demand improves	07:04am	RE
Thermo Fisher's Fiscal Q1 Adjusted Earnings Rise While Revenue Falls; Fiscal 2024 Outlook Updated -- Shares Advance Pre-Bell	06:47am	MT
Thermo Fisher Scientific 1Q Revenue Tops Estimates, Raises 2024 Outlook	06:38am	DJ
Thermo Fisher: Q1 Earnings Snapshot	06:07am	AQ
Thermo Fisher Scientific to Host Investor Day	06:06am	BU
Earnings Flash (TMO) THERMO FISHER SCIENTIFIC Reports Q1 Revenue $10.35B, vs. Street Est of $10.18B	06:03am	MT
Earnings Flash (TMO) THERMO FISHER SCIENTIFIC Reports Q1 EPS $5.11, vs. Street Est of $4.71	06:03am	MT
Thermo Fisher Scientific Reports First Quarter 2024 Results	06:01am	BU
Thermo Fisher Scientific Inc. Raises Revenue Guidance for the Full Year 2024	06:00am	CI
Bernstein Adjusts Price Target on Thermo Fisher Scientific to $544 From $520, Market Perform Rating Kept	Apr. 22	MT
Baird Adjusts Price Target on Thermo Fisher Scientific to $621 From $597	Apr. 22	MT
Ascential Medical & Life Sciences Appoints Anupam Girdhar as Divisional CEO	Apr. 17	AQ
TD Cowen Raises Price Target on Thermo Fisher Scientific to $644 From $612	Apr. 17	MT
HSBC Adjusts Thermo Fisher Scientific Price Target to $660 From $630	Apr. 17	MT
Thermo Fisher Scientific Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing	Apr. 12	AQ
Dicot in preparation for clinical phase 2a trial	Apr. 12	AQ
Thermo Fisher Scientific Inc. Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing	Apr. 11	CI
Thermo Fisher Scientific Innovations at Analytica 2024 Optimize Workflows and Enable Precise Analysis across Life Sciences, Applied and Industrial Markets	Apr. 10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Thermo Fisher Scientific

Equities

TMO

US8835561023

Summary

Filters